Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia And Metabolic Syndrome
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2010, Vol 17, Issue 4
Abstract
Introduction and Objective: The aim of this study was to evaluate the relationship between lower urinary tract symptoms (LUTS), benign prostatic hyperplasia, and metabolic syndrome. Methods: 381 patients, over 45 years, with metabolic syndrome were divided in 2 groups: group A – 310 patients with BHP (MetS+BPH) and, group B – 71 patients without BPH (MetS-BPH). Fasting concentrations of plasma glucose, HbA1c, serum lipides (total cholesterol, triglycerides, high-density lipoprotein HDL-C), insulin, and prostate-specific antigen (PSA) were measured under standardised conditions at baseline, 6 months and one year. IR (insulin resistance) was determinated using homeostasis model assessment (HOMA-IR). The presence of LUTS was assessed using the International Prostate Symptoms Score. The prostate gland volume was measured using transrectal ultrasound (prostate volume over 30 cm3 was considered prostatic hyperplasia). Results: Prevalence of severe LUTS was 14.8% (n=46) in BPH patients and 4.2% (n=3) patients without prostatic diseases (0.032). Prevalence of moderate LUTS was 74.2% (n=230) in BPH patients and 78.9% (n=56) patients without prostatic diseases (0.032). IPSS score correlated positively with age, BMI, triglycerides, HDL-cholestrol, and HbA1c. Conclusion: LUTS are frequent in metabolic syndrome patients with or without benign prostatic hyperplasia. In patients with all five components of MetS there was an increased prevalence of LUTS. Resulting from this study it is our reccomendation that patients with MetS need follow up/seek advice from an urological specialist as well.
Authors and Affiliations
Florin Rusu, Emilia Rusu, Gabriela Radulian, Georgiana Enache, Mariana Jinga, Viorel Jinga, Dan Mischianu
Keywords
Related Articles
- EP ID EP102677
- DOI -
- Views 152
- Downloads 0
THE EPIDEMIOLOGY OF DIABETIC NEUROPATHY
One of the major complications of diabetes mellitus (DM) is represented by the diabetic neuropathy (DN). Different peripheral nerves may be affected through many pathological processes and, therefore, there are many type...
PREDICTORS OF CHANGES IN PHYSICAL PROPERTIES OF SKIN IN PATIENTS WITH DIABETES MELLITUS
Introduction: The skin, the largest human organ, is often affected by diabetes mellitus (DM). We know that DM affects the hydration of stratum corneum (SC), the sebum content of the skin and to some extent, the bar...
CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER IN DIABETES MELLITUS PATIENTS
Diabetes mellitus (DM) and chronic kidney disease (CKD) are two diseases with increasing prevalence and adverse outcomes that represent an international health problem. Chronic kidney disease- mineral and bone diso...
PANCREATIC INSULINOMA PRESENTING WITH POSTPRANDIAL HYPOGLICEMIAS
We report the case of an obese 58 years old patient evaluated for hypoglycemia. The response to a prolonged fasting test was normal, but symptomatic hypoglycemia ensued after mixed meals and with oral glucose loadi...
FISH CONSUMPTION AND THE RISK OF TYPE 2 DIABETES
It is currently estimated that 285 million people suffer from diabetes in the world and by the year 2025 will be double. Diabetes mellitus appears to confer an excess risk of cardiovascular disease and premature death. A...